Regenxbio

14.97
+1.46
+10.81%
RGNX
 15.10 13.79 21.94万股总市值 7.58亿
 13.51 0.43% 315.83万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Regenxbio(RGNX)
12-15 19:25  
$Regenxbio(RGNX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003711  Act: 33  Size: 1 KB 网页链接
用户头像
Regenxbio(RGNX)
11-27 05:25  
$Regenxbio(RGNX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-25-300539  Act: 33  Size: 622 KB 网页链接
用户头像
Regenxbio(RGNX)
11-06 20:45  
$Regenxbio(RGNX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-268101  Act: 34  Size: 533 KB 网页链接
用户头像
Regenxbio(RGNX)
11-06 20:35  
$Regenxbio(RGNX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-268095  Act: 34  Size: 13 MB 网页链接
用户头像
Regenxbio(RGNX)
10-11 06:45  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001346164-25-000005  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
10-10 04:25  
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-007868  Act: 33  Size: 6 KB 网页链接
用户头像
Regenxbio(RGNX)
10-02 05:05  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001346164-25-000003  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
09-13 04:35  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-25-006194  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
09-11 04:45  
$Regenxbio(RGNX)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-006948  Act: 33  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
09-04 04:55  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-25-006078  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
09-04 04:55  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-25-006079  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
08-19 05:15  
$Regenxbio(RGNX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-109829  Act: 34  Size: 207 KB 网页链接
用户头像
Regenxbio(RGNX)
08-15 04:35  
$Regenxbio(RGNX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-078638  Act: 34  Size: 18 KB 网页链接
用户头像
Regenxbio(RGNX)
08-07 19:35  
$Regenxbio(RGNX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-174953  Act: 34  Size: 15 MB 网页链接
用户头像
Regenxbio(RGNX)
08-07 19:25  
$Regenxbio(RGNX)$ 8-K Current report, items 1.01, 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-174947  Act: 34  Size: 616 KB 网页链接
用户头像
Regenxbio(RGNX)
08-05 05:25  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-25-005618  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
07-16 05:15  
$Regenxbio(RGNX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002052113-25-002222  Act: 34  Size: 10 KB 网页链接
用户头像
Regenxbio(RGNX)
07-04 06:55  
$Regenxbio(RGNX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-25-005334  Size: 5 KB 网页链接
用户头像
Regenxbio(RGNX)
06-26 18:05  
$Regenxbio(RGNX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002024  Act: 33  Size: 1 KB 网页链接
用户头像
Regenxbio(RGNX)
06-26 04:25  
$Regenxbio(RGNX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-25-146911  Act: 33  Size: 254 KB 网页链接